RESEARCH
Platelet Rich Plasma and Stem Cell Therapy: Setting Standards and Evidence .
Biologics such as platelet-rich plasma (PRP) and stem cell therapies are increasingly used in orthopaedic care, yet high-quality evidence supporting their efficacy remains limited. This piece examines current scientific and regulatory challenges, including inconsistencies in PRP preparation, lack of standardized protocols, and methodological issues in clinical trials. Emphasis is placed on the need for rigorous evaluation and evidence-based guidance to support safe and effective integration into clinical practice.
Already have an account? Log in
Unlock the Full original article
You have access to 4 more FREE articles this month.
Click below to unlock and view this original article
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
